Genome-wide epigenetic modifications in cancer

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• Epigenetic alterations, including DNA methylation and histone modifications, are hallmarks of cancer, influencing chromatin states and gene expression.
• These changes contribute to chromosomal instability and altered transcriptional control, leading to distinct gene expression patterns in malignancies.

Purpose of the Study:

• To review current knowledge of epigenetic patterns and gene regulation in healthy versus cancer tissues, focusing on DNA methylation.
• To discuss advancements in technologies for measuring epigenetic alterations, particularly next-generation sequencing.
• To explore translational applications of epigenetic information, emphasizing DNA methylation for early disease detection and prognosis.

Main Methods:

• Review of existing literature on cancer epigenetics, DNA methylation, and histone modifications.
• Analysis of technological advancements in epigenome profiling, including next-generation sequencing.
• Examination of studies on the clinical utility of epigenetic markers in oncology.

Main Results:

• Epigenetic alterations are widespread in cancer genomes, impacting gene expression and contributing to disease phenotypes.
• Next-generation sequencing has transformed the ability to comprehensively map genome-wide epigenetic changes.
• DNA methylation patterns show significant potential for early cancer detection and prognostic assessment.

Conclusions:

• Understanding cancer epigenetics is crucial for deciphering malignancy development and progression.
• Technological innovations are rapidly advancing the field, enabling deeper insights into epigenetic regulation.
• Epigenetic marks, particularly DNA methylation, hold promise for revolutionizing cancer diagnostics and treatment strategies.